製品の概要

  • 製品名Anti-ITCH/AIP4 antibody
    ITCH/AIP4 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to ITCH/AIP4
  • アプリケーション適用あり: WB, ELISAmore details
  • 種交差性
    交差種: Mouse, Human
  • 免疫原

    Synthetic non-phosphopeptide derived from human ITCH/AIP4 around the phosphorylation site of tyrosine 420 (F-I-YP-G-N).

  • ポジティブ・コントロール
    • Extracts from mouse brain cells.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • バッファーPreservative: 0.02% Sodium Azide
    Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab79303 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/500 - 1/1000. Predicted molecular weight: 103 kDa.
ELISA 1/40000.

ターゲット情報

  • 機能Acts as an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. It catalyzes 'Lys-29'-, 'Lys-48'- and 'Lys-63'-linked ubiquitin conjugation. It is involved in the control of inflammatory signaling pathways. Is an essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, TAX1BP1 and RNF11, that ensures the transient nature of inflammatory signaling pathways. Promotes the association of the complex after TNF stimulation. Once the complex is formed, TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteosomal degradation and consequently termination of the TNF- or LPS-mediated activation of NFKB1. Ubiquitinates RIPK2 by 'Lys-63'-linked conjugation and influences NOD2-dependent signal transduction pathways. Regulates the transcriptional activity of several transcription factors, and probably plays an important role in the regulation of immune response. Ubiquitinates NFE2 by 'Lys-63' linkages and is implicated in the control of the development of hematopoietic lineages. Critical regulator of T helper (TH2) cytokine development through its ability to induce JUNB ubiquitination and degradation (By similarity). Ubiquitinates SNX9. Ubiquitinates CXCR4 and HGS/HRS and regulates sorting of CXCR4 to the degradative pathway. It is involved in the negative regulation of MAVS-dependent cellular antiviral responses. Ubiquitinates MAVS through 'Lys-48'-linked conjugation resulting in MAVS proteosomal degradation. Involved in the regulation of apoptosis and reactive oxygen species levels through the ubiquitination and proteosomal degradation of TXNIP. Mediates the antiapoptotic activity of epidermal growth factor through the ubiquitination and proteosomal degradation of p15 BID. Targets DTX1 for lysosomal degradation and controls NOTCH1 degradation, in the absence of ligand, through 'Lys-29'-linked polyubiquitination.
  • 組織特異性Widely expressed.
  • パスウェイProtein modification; protein ubiquitination.
  • 関連疾患Defects in ITCH are the cause of syndromic multisystem autoimmune disease (SMAD) [MIM:613385]. SMAD is characterized by organomegaly, failure to thrive, developmental delay, dysmorphic features and autoimmune inflammatory cell infiltration of the lungs, liver and gut.
  • 配列類似性Contains 1 C2 domain.
    Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.
    Contains 4 WW domains.
  • 翻訳後修飾On T-cell activation, phosphorylation by the JNK cascade on serine and threonine residues surrounding the PRR domain accelerates the ubiquitination and degradation of JUN and JUNB. The increased ITCH catalytic activity due to phosphorylation by JNK1 may occur due to a conformational change disrupting the interaction between the PRR/WW motifs domain and the HECT domain and, thus exposing the HECT domain (By similarity). Phosphorylation by FYN reduces interaction with JUNB and negatively controls JUN ubiquitination and degradation.
    Ubiquitinated; autopolyubiquitination with 'Lys-63' linkages which does not lead to protein degradation.
  • 細胞内局在Cell membrane. Cytoplasm. Nucleus. Associates with endocytic vesicles. May be recruited to exosomes by NDFIP1.
  • Information by UniProt
  • 参照データベース
  • 別名
    • ADMFD antibody
    • AIF4 antibody
    • AIP4 antibody
    • Atrophin 1 interacting protein 4 antibody
    • Atrophin-1-interacting protein 4 antibody
    • dJ468O1.1 antibody
    • dJ468O1.1 (atrophin 1 interacting protein 4 (AIP4)) antibody
    • dJ468O1.1 atrophin 1 interacting protein 4 AIP4 antibody
    • E3 ubiquitin protein ligase Itchy homolog antibody
    • E3 ubiquitin-protein ligase Itchy homolog antibody
    • EC 6.3.2 antibody
    • Itch antibody
    • ITCH_HUMAN antibody
    • Itchy E3 ubiquitin protein ligase antibody
    • Itchy E3 ubiquitin protein ligase homolog antibody
    • Itchy E3 ubiquitin protein ligase homolog mouse antibody
    • Itchy E3 ubiquitin protein ligase, mouse, homolog of antibody
    • Itchy homolog E3 ubiquitin protein ligase antibody
    • Itchy mouse homolog E3 ubiquitin protein ligase antibody
    • NAPP1 antibody
    • NFE2 associated polypeptide 1 antibody
    • NFE2-associated polypeptide 1 antibody
    • Ubiquitin protein ligase ITCH antibody
    see all

Anti-ITCH/AIP4 antibody 画像

  • All lanes : Anti-ITCH/AIP4 antibody (ab79303) at 1/500 dilution

    Lane 1 : Extracts from mouse brain cells
    Lane 2 : Extracts from mouse brain cells with immunising peptide at 10 µg

    Lysates/proteins at 30 µg per lane.


    Predicted band size : 103 kDa
    Observed band size : 103 kDa

Anti-ITCH/AIP4 antibody (ab79303) 使用論文

ab79303 has not yet been referenced specifically in any publications.

Product Wall

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Western blot
Sample Human Cell lysate - whole cell (293T cell)
Loading amount 50 µg
Specification 293T cell
Treatment siRNA
Gel Running Conditions Reduced Denaturing (8%)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Abcam user community

Verified customer

投稿 May 23 2012

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"